CN Stock MarketDetailed Quotes
605177 Zhejiang East-Asia Pharmaceutical
- 20.44
- +1.84+9.89%
Market Closed Sep 30 15:00 CST
2.35BMarket Cap23.66P/E (TTM)
20.46High19.06Low34.38KlotVolume19.34Open18.60Pre Close68.34MTurnover3.00%Turnover Ratio19.34P/E (Static)114.75MShares34.5752wk High1.24P/B2.35BFloat Cap14.6452wk Low20.46Limit Up114.75MShs Float56.09Historical High16.74Limit Down7.53%Amplitude14.64Historical Low0.33Dividend TTM19.88Avg Price17.46KlotAsk1.60%Div YieldTTM100Lot Size15.81KlotBid
Zhejiang East-Asia Pharmaceutical Key Stats
EPS
According to the latest financial report of Zhejiang East-Asia Pharmaceutical, the latest earnings per share (TTM) for the company is 0.22. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Zhejiang East-Asia Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 16.51.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zhejiang East-Asia Pharmaceutical shows that the company's current ratio is 2.80, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zhejiang East-Asia Pharmaceutical, the quick ratio is 1.59, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Zhejiang East-Asia Pharmaceutical? The latest ROE figure is 1.61%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zhejiang East-Asia Pharmaceutical, the total asset return on investment (ROA) is 0.97%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zhejiang East-Asia Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 25.81%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zhejiang East-Asia Pharmaceutical, the net profit margin is 5.01%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data